Narasimhan is confident that Novartis will achieve its goal of increasing sales by an average of 5% annually by 2028.

Credit: Elle Aon/Shutterstock. Novartis has received US Food and Drug Administration (FDA) accelerated approval for Scemblix (asciminib) to treat adults with newly diagnosed Philadelphia ...

Novartis posted third-quarter results that beat analysts' estimates and raised its full-year outlook, buoyed by strong sales of drugs like breast-cancer treatment Kisqali. The Swiss pharmaceutical ...

“We are proud to help redefine CML treatment once again with Scemblix, as we continue to deliver on our 20+ year commitment to innovation and support in CML,” said Victor Bulto, President US, Novartis ...

Swiss pharmaceutical giant Novartis raised its 2024 financial targets Tuesday after posting rising sales and margins in the third quarter, thanks in part to increased production of a prostate ...

Swiss pharmaceutical giant Novartis raised its 2024 financial targets Tuesday after posting rising sales and margins in the third quarter, thanks in part to increased production of a prostate cancer ...

Office workers walk out for a lunch break at Raffles Place central business district in Singapore on Oct 6, 2022. (File photo: AFP/Roslan RAHMAN) New: You can now listen to articles. SINGAPORE ...

C3G is a severe kidney disease that often leads to kidney failure within ten years of diagnosis. Credit: Orawan Pattarawimonchai/Shutterstock. Novartis has announced ...